Skip to main content

Table 2 Association of leptin, E-selectin and sub fractions of lipoprotein with neck circumference according to sex, considering the entire sample and individuals at low cardiovascular risk

From: Neck circumference is associated with non-traditional cardiovascular risk factors in individuals at low-to-moderate cardiovascular risk: cross-sectional analysis of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

 

Leptin

E-selectin

Small-dense LDL-C

HDL2-C

β

95% CI

p

β

95% CI

p

β

95% CI

p

β

95% CI

p

Entire sample

 Men

  Neck circumference

0.155

0.069 to 0.242

< 0.001

0.105

0.032 to 0.177

0.005

1.866

0.641 to 3.091

0.003

− 0.519

− 0.773 to − 0.266

< 0.001

 Women

  Neck circumference

0.147

0.075 to 0.220

< 0.001

0.73

0.006 to 0.140

0.032

2.372

1.391 to 3.353

< 0.001

− 0.815

− 1.115 to − 0.515

< 0.001

Lower risk subsample

 Men

  Neck circumference

0.183

0.084 to 0.282

< 0.001

0.95

0.015 to 0.175

0.021

1.758

0.478 to 3.039

0.007

− 0.476

− 0.766 to − 0.186

0.001

 Women

  Neck circumference

0.152

0.075 to 0.229

< 0.001

0.068

− 0.004 to 0.140

0.066

1.620

0.597 to 2.643

0.002

− 0.685

− 1.013 to − 0.356

< 0.001

Higher risk subsample

 Men

  Neck circumference

0.001

− 0.103 to 0.103

0.995

0.074

− 0.033 to 0.181

0.173

− 2.520

− 6.299 to 1.260

0.187

0.165

− 0.273 to 0.640

0.454

 Women

  Neck circumference

− 0.014

− 0.068 to 0.041

0.619

0.015

− 0.034 to 0.064

0.545

1.610

− 1.484 to 4.705

0.300

− 0.076

− 0.514 to 0.667

0.796

  1. Linear regression analysis. Adjusted for age. Lower risk subsample—individuals with up to 2 cardiovascular risk factors. Higher risk subsample—3 or more cardiovascular risk factors. Traditional cardiovascular risk factors: (1) waist circumference ≥ 102 cm for men or ≥ 88 cm for women; (2) systolic or diastolic blood pressure ≥ 130/85 mmHg or antihypertensive treatment; (3) fasting plasma glucose ≥ 100 mg/dL and < 126 mg/dL in the absence of antidiabetic agents; (4) triglyceride ≥ 150 mg/dL, or specific treatment; (5) HDL-cholesterol < 40 mg/dL for men and < 50 mg/dL for women, or specific treatment